Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical stu... Read more
REVOLUTION Medicines
19 followers
Owkin
9 followers
Krystal Biotech
8 followers
4D Molecular Therapeutics
8 followers
Dyne Therapeutics
6 followers
Rigel Pharmaceuticals
5 followers
Stemline Therapeutics
4 followers
Viridian Therapeutics
2 followers
Relay Therapeutics
2 followers
Entrada Therapeutics
2 followers
Terray Therapeutics
2 followers
Vibrant Wellness
2 followers